المؤلفون: Carlos Cervera, Camillo Ribi, José María Aguado, Oriol Manuel, Olivier Michielin, Mario Fernández-Ruiz, Gil Redelman-Sidi

المصدر: Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid

مصطلحات موضوعية: Microbiology (medical), Consensus, Efalizumab, Alefacept, Proteasome inhibitors, Antibodies, Monoclonal, Humanized, medicine.disease_cause, Communicable Diseases, Vedolizumab, Article, Immunocompromised Host, 03 medical and health sciences, 0302 clinical medicine, Natalizumab, Progressive multifocal leukoencephalopathy, Cell Adhesion, Humans, Medicine, CTLA-4 Antigen, Molecular Targeted Therapy, 030212 general & internal medicine, Clinical Trials as Topic, business.industry, Leukoencephalopathy, Progressive Multifocal, Varicella zoster virus, Antibodies, Monoclonal, Fingolimod, General Medicine, medicine.disease, Ipilimumab, Immune checkpoint, Biological Therapy, Genes, cdc, Receptors, Lysosphingolipid, Nivolumab, Infectious Diseases, Immunology, Infection, business, Pembrolizumab, Proteasome Inhibitors, 030217 neurology & neurosurgery, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4021ef76ba0a7441178ca7fb4d893d2b
https://doi.org/10.1016/j.cmi.2018.01.030